cetylpyridinium chloride anhydrous has been researched along with Cardiomyopathy, Dilated in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aliakbari, S; Ghaemian, A; Saeedi Saravi, SS; Salehifar, E; Shokrzadeh, M | 1 |
| Bär, H; Ehlermann, P; Geiger, SK; Herrmann, H; Ivandic, BT; Katus, HA; Rutschow, D; Wälde, S; Weichenhan, D; Zeller, R; Zentgraf, H | 1 |
2 other study(ies) available for cetylpyridinium chloride anhydrous and Cardiomyopathy, Dilated
| Article | Year |
|---|---|
The study of Cu and Zn serum levels in idiopathic dilated cardiomyopathy (IDCMP) patients and its comparison with healthy volunteers.
Topics: Adult; Cardiomyopathy, Dilated; Case-Control Studies; Copper; Female; Health; Humans; Male; Middle Aged; Zinc | 2008 |
Incomplete nonsense-mediated decay of mutant lamin A/C mRNA provokes dilated cardiomyopathy and ventricular tachycardia.
Topics: Adult; Alleles; Cardiomyopathy, Dilated; Case-Control Studies; Cell Nucleus; Chromatin; Codon, Nonsense; Down-Regulation; Female; Fibroblasts; Health; Humans; Lamin Type A; Male; Mutant Proteins; Myocardium; Nuclear Proteins; Pedigree; Proteasome Inhibitors; RNA Stability; RNA, Messenger; Skin; Tachycardia, Ventricular | 2008 |